These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37522845)

  • 1. Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-volume Center Retrospective Cohort Analysis.
    Wirsik NM; Schmidt T; Nienhüser H; Donlon NE; de Jongh C; Uzun E; Fuchs HF; Brunner S; Alakus H; Hölscher AH; Grimminger P; Schneider M; Reynolds JV; van Hillegersberg R; Bruns CJ
    Ann Surg; 2023 Nov; 278(5):683-691. PubMed ID: 37522845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
    BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transthoracic esophagectomy compared to transhiatal extended gastrectomy for adenocarcinoma of the esophagogastric junction: a multicenter retrospective cohort study.
    De Pasqual CA; van der Sluis PC; Weindelmayer J; Lagarde SM; Giacopuzzi S; De Manzoni G; Wijnhoven BPL
    Dis Esophagus; 2022 Aug; 35(8):. PubMed ID: 34969080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
    Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
    Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary outcomes for resected type 1-3 gastroesophageal junction adenocarcinoma: a single-center experience.
    Stiles ZE; Hagerty BL; Brady M; Mukherjee S; Hochwald SN; Kukar M
    J Gastrointest Surg; 2024 May; 28(5):634-639. PubMed ID: 38704200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of transabdominal and transthoracic surgical approaches in the treatment of Siewert type II esophagogastric junction cancers: A propensity score-matching analysis.
    Oh SE; Lee GH; An JY; Lee JH; Sohn TS; Bae JM; Kim S; Choi MG
    Eur J Surg Oncol; 2022 Feb; 48(2):370-376. PubMed ID: 34433514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis.
    Kamarajah SK; Phillips AW; Griffiths EA; Ferri L; Hofstetter WL; Markar SR
    Ann Surg Oncol; 2021 Dec; 28(13):8485-8494. PubMed ID: 34255246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?
    Blank S; Schmidt T; Heger P; Strowitzki MJ; Sisic L; Heger U; Nienhueser H; Haag GM; Bruckner T; Mihaljevic AL; Ott K; Büchler MW; Ulrich A
    Gastric Cancer; 2018 Mar; 21(2):303-314. PubMed ID: 28685209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative complications after a transthoracic esophagectomy or a transhiatal gastrectomy in patients with esophagogastric junctional cancers: a prospective nationwide multicenter study.
    Mine S; Kurokawa Y; Takeuchi H; Terashima M; Yasuda T; Yoshida K; Yabusaki H; Shirakawa Y; Fujitani K; Sano T; Doki Y; Kitagawa Y
    Gastric Cancer; 2022 Mar; 25(2):430-437. PubMed ID: 34590178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side.
    Hölscher AH; Bollschweiler E; Fetzner UK; Babic B
    Updates Surg; 2023 Feb; 75(2):329-333. PubMed ID: 36001282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 15. RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
    Lorenzen S; Biederstädt A; Ronellenfitsch U; Reißfelder C; Mönig S; Wenz F; Pauligk C; Walker M; Al-Batran SE; Haller B; Hofheinz RD
    BMC Cancer; 2020 Sep; 20(1):886. PubMed ID: 32933498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophagectomy vs Gastrectomy for Early Stage Adenocarcinoma of the Gastroesophageal Junction: What is the Optimal Oncologic Surgical Treatment?
    Holguin RAP; Wong WG; Shen C; Go PH; Reed MF; Taylor MD
    Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):807-819. PubMed ID: 35926763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transhiatal distal esophagectomy for Siewert type II cardia cancer can be a treatment option in selected patients.
    Reddavid R; Strignano P; Sofia S; Evangelista A; Deiro G; Cannata G; Chiaro P; Maiello F; Mineccia M; Ferrero A; Leli R; Gentilli S; Polastri R; Borghi F; Camandona M; Romagnoli R; Morino M; Degiuli M
    Eur J Surg Oncol; 2019 Oct; 45(10):1943-1949. PubMed ID: 31005469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern diagnostics and stage-oriented surgery: therapy of adenocarcinoma of the esophagogastric junction].
    Hölscher AH; Fetzner UK
    Chirurg; 2012 Aug; 83(8):702-8, 710-1. PubMed ID: 22878576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis.
    Parry K; van Rossum PS; Haj Mohammad N; Ruurda JP; van Hillegersberg R
    Eur J Surg Oncol; 2017 Jan; 43(1):226-233. PubMed ID: 27424786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.